EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dual and triple gene combinations of KRT5 , KRT17 , and S100A2 identify basal‐like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcome

Qiangxing Chen iD, Zixin Chen iD, Jing Zhang iD, Yunqiang Cai iD, Shangdi Wu iD, Du He iD, Ke Cheng iD, Xiafei Gu iD, Yu Cai iD, Xin Wang iD, Yongbin Li iD, Man Zhang iD und 2 weitere

The FASEB Journal · 2024

DOI: 10.1096/fj.202302484rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Qiangxing Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pancreatic Surgery, Department of General Surgery, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Biomarkers, Tumor, S100 Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a significant difference in prognosis and response to chemotherapy between basal and classical subtypes of pancreatic ductal adenocarcinoma (PDAC). Further biomarkers are required to identify subtypes of PDAC. We selected candidate biomarkers via review articles. Correlations between these candidate markers and the PDAC molecular subtype gene sets were analyzed using bioinformatics, confirming the biomarkers for identifying classical and basal subtypes. Subsequently, 298 PDAC patients were included, and their tumor tissues were immunohistochemically stratified using these biomarkers. Survival data underwent analysis, including Cox proportional hazards modeling. Our results indicate that the pairwise and triple combinations of KRT5/KRT17/S100A2 exhibit a higher correlation coefficient with the basal‐like subtype gene set, whereas the corresponding combinations of GATA6/HNF4A/TFF1 show a higher correlation with the classical subtype gene set. Whether analyzing unmatched or propensity‐matched data, the overall survival time was significantly shorter for the basal subtype compared with the classical subtype ( p < .001), with basal subtype patients also facing a higher risk of mortality (HR = 4.017, 95% CI 2.675–6.032, p < .001). In conclusion, the combined expression of KRT5, KRT17, and S100A2, in both pairwise and triple combinations, independently predicts shorter overall survival in PDAC patients and likely identifies the basal subtype. Similarly, the combined expression of GATA6, HNF4A, and TFF1, in the same manner, may indicate the classical subtype. In our study, the combined application of established biomarkers offers valuable insights for the prognostic evaluation of PDAC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsBiomarkers, TumorS100 ProteinsKeratin-5Keratin-17HumansMaleFemaleMiddle AgedAgedPrognosisGATA6 Transcription FactorGene Expression Regulation, NeoplasticAdultHepatocyte Nuclear Factor 4Chemotactic Factors

Stichwörter der Autor:innen

basalbiomarkerclassicalmolecular subtypespancreatic ductal adenocarcinoma

Substanzen

Biomarkers, TumorS100A2 protein, humanS100 ProteinsKeratin-5Keratin-17KRT17 protein, humanKRT5 protein, humanGATA6 Transcription FactorGATA6 protein, humanHepatocyte Nuclear Factor 4

Autor:innen und Institutionen

  • Division of Pancreatic Surgery, Department of General Surgery, West China Hospital of Sichuan University, Chengdu, China.
  • West China School of Medicine, West China Hospital of Sichuan University, Chengdu, China.
  • Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Division of Liver Surgery, Department of General Surgery, West China Hospital of Sichuan University, Chengdu, China.
  • Department of General Surgery, Nanchong Central Hospital, The Second Clinical College of North Sichuan Medical College, Nanchong, Sichuan, China.
  • Department of Minimal Invasive Surgery, Shangjin Nanfu Hospital, Chengdu, China.

ORCID-Profile: Qiangxing Chen, Zixin Chen, Jing Zhang, Yunqiang Cai, Shangdi Wu, Du He, Ke Cheng, Xiafei Gu, Yu Cai, Xin Wang, Yongbin Li, Man Zhang, Zhong Wu, Bing Peng

Förderung

  • 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University

Zitieren

APA

Chen, Q., Chen, Z., Zhang, J., Cai, Y., Wu, S., He, D., Cheng, K., Gu, X., Cai, Y., Wang, X., Li, Y., Zhang, M., Wu, Z., & Peng, B. (2024). Dual and triple gene combinations of KRT5 , KRT17 , and S100A2 identify basal‐like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcome. The FASEB Journal. https://doi.org/10.1096/fj.202302484rr

Vancouver

Chen Q, Chen Z, Zhang J, Cai Y, Wu S, He D, et al. Dual and triple gene combinations of KRT5 , KRT17 , and S100A2 identify basal‐like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcome. The FASEB Journal. 2024. doi:10.1096/fj.202302484rr

BibTeX
@article{Chen2024,
  author = {Chen, Qiangxing and Chen, Zixin and Zhang, Jing and Cai, Yunqiang and Wu, Shangdi and He, Du and Cheng, Ke and Gu, Xiafei and Cai, Yu and Wang, Xin and Li, Yongbin and Zhang, Man and Wu, Zhong and Peng, Bing},
  title = {Dual and triple gene combinations of KRT5 , KRT17 , and S100A2 identify basal‐like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcome},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202302484rr}
}
Kostenlos starten →